Viewing Study NCT06814106


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-29 @ 6:52 PM
Study NCT ID: NCT06814106
Status: COMPLETED
Last Update Posted: 2025-02-07
First Post: 2025-02-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module